---
figid: PMC3579099__kjpp-17-1-g001
figlink: /pmc/articles/PMC3579099/figure/F1/
number: F1
caption: The calcineurin-NFAT pathway as an integrator of multiple signaling pathways
  in the pathogenesis of pulmonary hypertension (PH). NFAT resides in the cytoplasm
  of resting cells in a phosphorylated and inactive state. Endothelial dysfunction
  occurs early in PH and results in an increased release of vasoconstrictors (Endothelin-1
  [ET-1] and 5-Hydroxytryptamine [5-HT]) and decreased vasodilators (Prostaglandin
  [PGI2] and nitric oxide synthase [NOS]). These vasoconstrictors can stimulate phospholipase
  C (PLC) coupled cell surface receptors leading to mobilization of calcium ions (Ca2+)
  from intracellular stores via inositol trisphosphate (IP3). The elevated intracellular
  calcium ([Ca2+]i) can cause further Ca2+ influx via Ca2+ release-activated Ca2+
  channels (CRAC). Addtionally, the down-regulation of Kv1.5 depolarized PASMC and
  will lead to the influx of via L-type voltage dependent Ca2+ channels (VDCC). The
  elevated [Ca2+]i activates phosphatase calcineurin which dephosphorylates NFAT allowing
  for its translocation to the nucleus. Here it is involved in the regulation of multiple
  genes. Multiple NFAT binding elements are present in the promoter regions of both
  the Kv1.5 and bcl-2 genes leading to a promotion of cell proliferation and suppressing
  mitochondrial-dependent apoptosis. Cyclosporin A inhibits calcineurin-ubstrate interactions
  and VIVITs electively inhibits NFAT activation.
pmcid: PMC3579099
papertitle: Regulation of Ca2+ Signaling in Pulmonary Hypertension.
reftext: Amy L. Firth, et al. Korean J Physiol Pharmacol. 2013 Feb;17(1):1-8.
pmc_ranked_result_index: '157898'
pathway_score: 0.8714719
filename: kjpp-17-1-g001.jpg
figtitle: Calcineurin-NFAT pathway as an integrator of multiple signaling pathways
  in the pathogenesis of pulmonary hypertension (PH)
year: '2013'
organisms:
- Homo sapiens
ndex: 4c284fca-df1c-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3579099__kjpp-17-1-g001.html
  '@type': Dataset
  description: The calcineurin-NFAT pathway as an integrator of multiple signaling
    pathways in the pathogenesis of pulmonary hypertension (PH). NFAT resides in the
    cytoplasm of resting cells in a phosphorylated and inactive state. Endothelial
    dysfunction occurs early in PH and results in an increased release of vasoconstrictors
    (Endothelin-1 [ET-1] and 5-Hydroxytryptamine [5-HT]) and decreased vasodilators
    (Prostaglandin [PGI2] and nitric oxide synthase [NOS]). These vasoconstrictors
    can stimulate phospholipase C (PLC) coupled cell surface receptors leading to
    mobilization of calcium ions (Ca2+) from intracellular stores via inositol trisphosphate
    (IP3). The elevated intracellular calcium ([Ca2+]i) can cause further Ca2+ influx
    via Ca2+ release-activated Ca2+ channels (CRAC). Addtionally, the down-regulation
    of Kv1.5 depolarized PASMC and will lead to the influx of via L-type voltage dependent
    Ca2+ channels (VDCC). The elevated [Ca2+]i activates phosphatase calcineurin which
    dephosphorylates NFAT allowing for its translocation to the nucleus. Here it is
    involved in the regulation of multiple genes. Multiple NFAT binding elements are
    present in the promoter regions of both the Kv1.5 and bcl-2 genes leading to a
    promotion of cell proliferation and suppressing mitochondrial-dependent apoptosis.
    Cyclosporin A inhibits calcineurin-ubstrate interactions and VIVITs electively
    inhibits NFAT activation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PLCE1
  - PPP3CB
  - PPP3CC
  - CASP4
  - CASP5
  - PLCB2
  - PPP3CA
  - BCL2
  - PPP3R2
  - NFATC1
  - CASP3
  - PPP3R1
  - NFATC2
  - PLCB4
  - PLCB1
  - PLCB3
  - VIP
  - NFAT5
  - CASP2
  - NFATC4
  - PLCD4
  - PLCD1
  - CASP6
  - PLCG2
  - NFATC3
  - PLCZ1
  - PLCD3
  - CASP1
  - CASP7
  - CASP8
  - CASP14
  - CASP12
  - EDN1
  - PLCG1
  - CASP10
  - CASP9
  - 5-HT
  - Cyclosporin A
genes:
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CB
  entrez: '5532'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CC
  entrez: '5533'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CA
  entrez: '5530'
- word: â€ bcl2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R2
  entrez: '5535'
- word: NFAT-P
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R1
  entrez: '5534'
- word: NFAT-P
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: NFAT-P
  symbol: NF-ATP
  source: hgnc_alias_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: VIP
  symbol: VIP
  source: hgnc_symbol
  hgnc_symbol: VIP
  entrez: '7432'
- word: NFAT-P
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFAT5
  entrez: '10725'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: NFAT-P
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC4
  entrez: '4776'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: NFAT-P
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC3
  entrez: '4775'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: (ET-1;
  symbol: ET1
  source: hgnc_alias_symbol
  hgnc_symbol: EDN1
  entrez: '1906'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
chemicals:
- word: 5-HT
  source: MESH
  identifier: D012701
- word: Cyclosporin A
  source: MESH
  identifier: D016572
diseases: []
figid_alias: PMC3579099__F1
redirect_from: /figures/PMC3579099__F1
figtype: Figure
---
